APA (7th ed.) Citation

A, B., G, S., G, D. S., M, M., M, C., S, T., . . . A, d. B. (2025). In vivo assessment of GABAergic inhibition and glutamate facilitation in treatment-resistant schizophrenia: A TMS study integrating clinical, cognitive, and neurophysiological evaluations. Schizophrenia (Heidelberg, Germany), 11(1), 90. https://doi.org/10.1038/s41537-025-00634-w

Chicago Style (17th ed.) Citation

A, Barone, et al. "In Vivo Assessment of GABAergic Inhibition and Glutamate Facilitation in Treatment-resistant Schizophrenia: A TMS Study Integrating Clinical, Cognitive, and Neurophysiological Evaluations." Schizophrenia (Heidelberg, Germany) 11, no. 1 (2025): 90. https://doi.org/10.1038/s41537-025-00634-w.

MLA (9th ed.) Citation

A, Barone, et al. "In Vivo Assessment of GABAergic Inhibition and Glutamate Facilitation in Treatment-resistant Schizophrenia: A TMS Study Integrating Clinical, Cognitive, and Neurophysiological Evaluations." Schizophrenia (Heidelberg, Germany), vol. 11, no. 1, 2025, p. 90, https://doi.org/10.1038/s41537-025-00634-w.